Artículo

Este artículo es de Acceso Abierto y puede ser descargado en su versión final desde nuestro repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

The immunogenicity and protective efficacy of recombinant lumazine synthase from Brucella spp. (rBLS) administered with different adjuvants was evaluated in mice. Mice were immunized with rBLS in the absence or the presence of aluminum hydroxide gel (BLS-A1), monophosphoryl lipid A (BLS-MPA), or incomplete Freund's adjuvant (BLS-IFA). rBLS per se induced a vigorous immunoglobulin G (IgG) response, with high titers of IgG1 as well as IgG2. All the adjuvants increased this response; the BLS-IFA formulation was the most effective at inducing BLS-specific IgG antibodies. In addition, after in vitro stimulation with rBLS, spleen cells from BLS-IFA-, BLS-A1-, or BLS-MPA-immunized mice proliferated and produced interleukin-2 (IL-2), gamma interferon (IFN-γ), IL-10, and IL-4, suggesting the induction of a mixed Th1-Th2 response. Immunization with rBLS protected mice against challenge with B. abortus 544. The levels of protection in the spleen were similar for all adjuvants, but only BLS-A1 and BLS-IFA were effective in the liver. Our results indicate that BLS might be a useful candidate for the development of subunit vaccines against brucellosis, since it elicits antigen-specific cellular responses, with production of IFN-γ and protection, independently of the adjuvant formulation used.

Registro:

Documento: Artículo
Título:Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used
Autor:Velikovsky, C.A.; Goldbaum, F.A.; Cassataro, J.; Estein, S.; Bowden, R.A.; Bruno, L.; Fossati, C.A.; Giambartolomei, G.H.
Filiación:Inst. Estud. de la Inmunidad Humoral, Facultad de Farmacia y Bioquimica, Buenos Aires, Argentina
Laboratorio de Inmunogenética, Hosp. de Clin. Jose de San Martin, Facultad de Medicina, Buenos Aires, Argentina
UBA, Fundacion Instituto Leloir, CONICET, FCEN-UBA, Buenos Aires, Argentina
Lab. de Inmunoquim. y Biotecnologia, Depto. de Sanid. Anim./Med. Prev., Facultad de Ciencias Veterinarias, Tandil, Argentina
Inst. Estud. de la Inmunidad Humoral, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Junín 956 4to Piso, (1113) Buenos Aires, Argentina
Ctr. for Adv. Res. in Biotechnology, Rockville, MD, United States
Palabras clave:aluminum hydroxide; Brucella vaccine; Freund adjuvant; gamma interferon; immunoglobulin G; immunoglobulin G antibody; immunoglobulin G1; immunoglobulin G2; interleukin 10; interleukin 2; interleukin 4; lumazine; lumazine synthase; phosphoryl lipid A; recombinant enzyme; unclassified drug; animal experiment; animal model; article; Brucella abortus; brucellosis; controlled study; cytokine production; drug effect; drug formulation; female; immune response; immunization; immunogenicity; mouse; nonhuman; priority journal; spleen cell; Th1 cell; Th2 cell; Adjuvants, Immunologic; Animals; Antibodies, Bacterial; Brucella; Brucella Vaccine; Brucellosis; Female; Lymphocyte Activation; Mice; Mice, Inbred BALB C; Multienzyme Complexes; Th1 Cells; Th2 Cells; Vaccines, Synthetic
Año:2003
Volumen:71
Número:10
Página de inicio:5750
Página de fin:5755
DOI: http://dx.doi.org/10.1128/IAI.71.10.5750-5755.2003
Título revista:Infection and Immunity
Título revista abreviado:Infect. Immun.
ISSN:00199567
CODEN:INFIB
CAS:aluminum hydroxide, 1330-44-5, 20257-20-9, 21645-51-2, 80206-84-4; Freund adjuvant, 9007-81-2; gamma interferon, 82115-62-6; immunoglobulin G, 97794-27-9; interleukin 2, 85898-30-2; lumazine, 487-21-8; phosphoryl lipid A, 88598-53-2; 6,7-dimethyl-8-ribityllumazine synthase, 89287-46-7; Adjuvants, Immunologic; Antibodies, Bacterial; Brucella Vaccine; Multienzyme Complexes; Vaccines, Synthetic
PDF:https://bibliotecadigital.exactas.uba.ar/download/paper/paper_00199567_v71_n10_p5750_Velikovsky.pdf
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00199567_v71_n10_p5750_Velikovsky

Referencias:

  • Aberle, J.H., Aberle, S.W., Allison, S.L., Stiasny, K., Ecker, M., Mandl, C.W., Berger, R., Heinz, F.X., A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms (1999) J. Immunol., 163, pp. 6756-6761
  • Al-Mariri, A., Tibor, A., Mertens, P., De Bolle, X., Michel, P., Godfroid, J., Walravens, K., Letesson, J.-J., Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp (2001) Infect. Immun., 69, pp. 6264-6270
  • Araya, L.N., Elzer, P.H., Rowe, G.H., Enright, F.M., Winter, A.J., Temporal development of protective cell-mediated and humoral immunity in BALB/c mice infected with Brucella abortus (1989) J. Immunol., 143, pp. 3330-3337
  • Araya, L.N., Winter, A.J., Comparative protection of mice against virulent and attenuated strains of Brucella abortus by passive transfer of immune T cells or serum (1990) Infect. Immun., 58, pp. 254-256
  • Bachmann, M.F., Zinkernagel, R.M., The influence of virus structure on antibody responses and virus serotype formation (1996) Immunol. Today, 17, pp. 553-558
  • Baldi, P.C., Velikovsky, C.A., Braden, B.C., Giambartolomei, G.H., Fossati, C.A., Goldbaum, F.A., Structural, functional and immunological studies on a polymeric bacterial protein (2000) Braz. J. Med. Biol. Res., 33, pp. 741-747
  • Baldi, P.C., Giambartolomei, G.H., Goldbaum, F.A., Abdón, L.F., Velikovsky, C.A., Kittelberger, R., Fossati, C.A., Humoral immune response against lipopolysaccharide and cytoplasmic proteins of Brucella abortus in cattle vaccinated with Brucella abortus S19 or experimentally infected with Yersinia enterocolitica serotype 0:9 (1996) Clin. Diagn. Lab. Immunol., 3, pp. 472-476
  • Baldi, P.C., Wanke, M.M., Loza, M.E., Monachesi, N., Fossati, C.A., Diagnosis of canine brucellosis by detection of IgG antibodies against an 18 kDa cytoplasmic protein of Brucella spp (1997) Vet. Microbiol., 57, pp. 273-281
  • Bowden, R.A., Cloeckaert, A., Zygmunt, M., Dubray, G., Outer membrane protein and rough lipopolysaccharide-specific monoclonal anti-bodies protect mice against Brucella ovis (1995) J. Med. Microbiol., 43, pp. 344-347
  • Braden, B.C., Velikovsky, C.A., Cauerhff, A.A., Polikarpov, I., Goldbaum, F.A., Divergence in macromolecular assembly: X-ray crystallographic structure analysis of lumazine synthase from Brucella abortus (2000) J. Mol. Biol., 297, pp. 1031-1036
  • Cespedes, S., Andrews, E., Folch, H., Onate, A., Identification and partial characterisation of a new protective antigen of Brucella abortus (2000) J. Med. Microbiol., 49, pp. 165-170
  • Chackerian, B., Lenz, P., Lowy, D.R., Schiller, J.T., Determinants of autoantibody induction by conjugated papillomavirus virus-like particles (2002) J. Immunol., 169, pp. 6120-6126
  • Cheers, C., Pathogenesis and cellular immunity in experimental murine brucellosis (1984) Dev. Biol. Stand., 56, pp. 237-246
  • Cheville, N.F., Kunkle, R.A., Jensen, A.E., Palmer, M.V., Persistence of Brucella abortus in the livers of T cell-deficient nude mice (1995) Lab. Investig., 73, pp. 96-102
  • Eze, M.O., Yuan, L., Crawford, R.M., Paranavitana, C.M., Hadfield, T.L., Bhattacharjee, A.K., Warren, R.L., Hoover, D.L., Effects of opsonization and gamma interferon on growth of Brucella melitensis 16M in mouse peritoneal macrophages in vitro (2000) Infect. Immun., 68, pp. 257-263
  • Falchetti, R., Di Francesco, P., Lanzilli, G., Gaziano, R., Casalinuovo, I.A., Palamara, A.T., Ravagnan, G., Garaci, E., Determination of cytokine co-expression in individual splenic CD4 + and CD8+ T cells from influenza virus-immune mice (1998) Immunology, 95, pp. 346-351
  • Fernandes, D., Baldwin, C., Interleukin-10 downregulates protective immunity to Brucella abortus (1995) Infect. Immun., 63, pp. 1130-1133
  • Goldbaum, F.A., Velikovsky, C.A., Baldi, P.C., Mortl, S., Bacher, A., Fossati, C.A., The 18-kDa cytoplasmic protein of Brucella spp.-an antigen useful for diagnosis-is a lumazine synthase (1999) J. Med. Microbiol., 48, pp. 833-839
  • Goldbaum, F.A., Leoni, J., Wallach, J.C., Fossati, C.A., Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis (1993) J. Clin. Microbiol., 31, pp. 2141-2145
  • Izadjoo, M.J., Polotsky, Y., Mense, M.G., Bhattacharjee, A.K., Paranavitana, C.M., Hadfield, T.L., Hoover, D.L., Impaired control of Brucella melitensis infection in Rag1-deficient mice (2000) Infect. Immun., 68, pp. 5314-5320
  • Jacques, I., Cloeckaert, A., Linet, J.N., Dubray, G., Protection conferred on mice by combinations of monoclonal antibodies directed against outer-membrane proteins or smooth lipopolysaccharide of Brucella (1992) J. Med. Microbiol., 37, pp. 100-103
  • Katayama, S., Oda, K., Ohgitani, T., Hirahara, T., Shimizu, Y., Influence of antigenic forms and adjuvants on the IgG subclass antibody response to Aujeszky's disease virus in mice (1999) Vaccine, 17, pp. 2733-2739
  • Miller, M.J., Wrightsman, R.A., Manning, J.E., Trypanosoma cruzi: Protective immunity in mice immunized with paraflagellar rod proteins is associated with a T-helper type 1 response (1996) Exp. Parasitol., 84, pp. 156-167
  • Murphy, E.A., Sathiyaseelan, J., Parent, M.A., Zou, B., Baldwin, C.L., Interferon-gamma is crucial for surviving a Brucella abortus infection in both resistant C57BL/6 and susceptible BALB/c mice (2001) Immunology, 103, pp. 511-518
  • Neuzil, K.M., Johnson, J.E., Tang, Y.W., Prieels, J.P., Slaoui, M., Gar, N., Graham, B.S., Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine (1997) Vaccine, 15, pp. 525-532
  • Nicoletti, P., Vaccination (1990) Animal Brucellosis, pp. 284-299. , K. Nielsen, and J. R. Duncan (ed.). CRC Press, Boca Raton, Fla
  • Nieba, L., Bachmann, M.F., A new generation of vaccines (2000) Mod. Asp. Immunobiol., 1, pp. 36-39
  • Oliveira, S.C., Splitter, G.A., Immunization of mice with recombinant L7/12 ribosomal protein confers protection against Brucella abortus infection (1996) Vaccine, 14, pp. 959-962
  • Pasquali, P., Adone, R., Gasbarre, L.C., Pistoia, C., Ciuchini, F., Mouse cytokine profiles associated with Brucella abortus RB51 vaccination or B. abortus 2308 infection (2001) Infect. Immun., 69, pp. 6541-6544
  • Schurig, G.G., Sriranganathan, N., Corbel, M.J., Brucellosis vaccines: Past, present and future (2002) Vet. Microbiol., 90, pp. 479-496
  • Schurig, G.G., Roop R.M. II, Bagchi, T., Boyle, S., Buhrman, D., Sriranganathan, N., Biological properties of RB51; a stable rough strain of Brucella abortus (1991) Vet. Microbiol., 28, pp. 171-188
  • Sulzer, B., Perelson, A.S., Immunons revisited: Binding of multivalent antigens to B cells (1997) Mol. Immunol., 34, pp. 63-74
  • Tabatabai, L.B., Pugh G.W., Jr., Modulation of immune responses in BALB/c mice vaccinated with Brucella abortus Cu-Zn superoxide dismutase synthetic peptide vaccine (1992) Vaccine, 12, pp. 919-924
  • Velikovsky, C.A., Cassataro, J., Giambartolomei, G.H., Goldbaum, F.A., Estein, S., Bowden, R.A., Bruno, L., Spitz, M., A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice (2002) Infect. Immun., 70, pp. 2507-2511
  • Victoratos, P., Yiangou, M., Avramidis, N., Hadjipetrou, I., Regulation of cytokine gene expression by adjuvants in vivo (1997) Clin. Exp. Immunol., 109, pp. 569-578
  • Yip, H.C., Karulin, A.Y., Tary-Lehmann, M., Hesse, M.D., Radeke, H., Heeger, P.S., Trezza, R.P., Lehmann, P.V., Adjuvant-guided type-1 and type-2 immunity: Infectious/noninfectious dichotomy defines the class of response (1999) J. Immunol., 162, pp. 3942-3949
  • Young, E.J., Human brucellosis (1983) Rev. Infect. Dis., 5, pp. 821-842
  • Zhan, Y., Cheers, C., Endogenous gamma interferon mediates resistance to Brucella abortus infection (1993) Infect. Immun., 61, pp. 4899-4901

Citas:

---------- APA ----------
Velikovsky, C.A., Goldbaum, F.A., Cassataro, J., Estein, S., Bowden, R.A., Bruno, L., Fossati, C.A.,..., Giambartolomei, G.H. (2003) . Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infection and Immunity, 71(10), 5750-5755.
http://dx.doi.org/10.1128/IAI.71.10.5750-5755.2003
---------- CHICAGO ----------
Velikovsky, C.A., Goldbaum, F.A., Cassataro, J., Estein, S., Bowden, R.A., Bruno, L., et al. "Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used" . Infection and Immunity 71, no. 10 (2003) : 5750-5755.
http://dx.doi.org/10.1128/IAI.71.10.5750-5755.2003
---------- MLA ----------
Velikovsky, C.A., Goldbaum, F.A., Cassataro, J., Estein, S., Bowden, R.A., Bruno, L., et al. "Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used" . Infection and Immunity, vol. 71, no. 10, 2003, pp. 5750-5755.
http://dx.doi.org/10.1128/IAI.71.10.5750-5755.2003
---------- VANCOUVER ----------
Velikovsky, C.A., Goldbaum, F.A., Cassataro, J., Estein, S., Bowden, R.A., Bruno, L., et al. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect. Immun. 2003;71(10):5750-5755.
http://dx.doi.org/10.1128/IAI.71.10.5750-5755.2003